^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    UltraSEEK® Colon Panel

    Company:
    Agena Bio
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The UltraSEEK® Colon Panel enables study of disease progression and resistance in colorectal cancer. Detect over 100 clinically relevant variants across BRAF, EGFR, KRAS, NRAS and PIK3CA. Indentify variants at as low as 0.1% variant allele frequency. se as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time
    Cancer:
    Colon Cancer
    Gene:
    BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), KRAS (KRAS proto-oncogene GTPase), NRAS (Neuroblastoma RAS viral oncogene homolog), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)